Cost‐effectiveness analysis of stent type in endoscopic treatment of gastric leak after laparoscopic sleeve gastrectomy. BJS 2018; 105: 570-577.
Published: 22nd February 2018
Authors: C. Cosse, L. Rebibo, F. Brazier, S. Hakim, R. Delcenserie, J. M. Regimbeau et al.
Gastric leak is the most feared surgical postoperative complication after sleeve gastrectomy. An endoscopic procedure is usually required to treat the leak. No data are available on the cost‐effectiveness of different stent types in this procedure.
Between April 2005 and July 2016, patients with a confirmed gastric leak undergoing endoscopic treatment using a covered stent (CS) or double‐pigtail stent (DPS) were included. The primary objective of the study was to assess overall costs of the stent types after primary sleeve gastrectomy. Secondary objectives were the cost‐effectiveness of each stent type expressed as an incremental cost‐effectiveness ratio (ICER); the incremental net benefit; the probability of efficiency, defined as the probability of being cost‐effective at a threshold of €30 000, and identification of the key drivers of ICER derived from a multivariable analysis.
One hundred and twelve patients were enrolled. The overall mean costs of gastric leak were €22 470; the mean(s.d.) cost was €24 916(12 212) in the CS arm and €20 024(3352) in the DPS arm (
DPS for the treatment of gastric leak is more cost‐effective than CS and should be proposed as the standard regimen whenever possible.Full text
You may also be interested in
Authors: M. Kanda, D. Shimizu, H. Tanaka, C. Tanaka, D. Kobayashi, M. Hayashi et al.
Notes: Potential target for therapy
Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection.
Authors: M. C. Halls, G. Berardi, F. Cipriani, L. Barkhatov, P. Lainas, S. Harris et al.
Notes: Helps improve selection for laparoscopic liver resection
Authors: D. Zeng, R. Zhou, Y. Yu, Y. Luo, J. Zhang, H. Sun et al.
Notes: Immunoscore predicts prognosis in gastric cancer
Reappraisal of classification of distal cholangiocarcinoma based on tumour depth. BJS 2018; 105: 867-875.
Authors: H. Aoyama, T. Ebata, M. Hattori, M. Takano, H. Yamamoto, M. Inoue et al.
Notes: Better for T staging
Authors: S. D. Nelen, K. Bosscha, V. E. P. P. Lemmens, H. H. Hartgrink, R. H. A. Verhoeven, J. H. W. de Wilt et al.
Notes: Age does not matter
Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography.
Authors: N. Sato, A. Kenjo, T. Kimura, R. Okada, T. Ishigame, Y. Kofunato et al.
Notes: liver stiffness predicts complications
Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.
Authors: W. T. A. van der Graaf, R. Tielen, J. J. Bonenkamp, V. Lemmens, R. H. A. Verhoeven, J. H. W. de Wilt et al.
Notes: Surgery improves survival
Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial. BJS 2018; 105: 728-735.
Authors: Y. H. M. Claassen, J. W. van Sandick, H. H. Hartgrink, J. L. Dikken, W. O. De Steur, N. C. T. van Grieken et al.
Notes: High volume better quality
Relationship between intraoperative non‐technical performance and technical events in bariatric surgery.
Authors: A. B. Fecso, S. S. Kuzulugil, C. Babaoglu, A. B. Bener, T. P. Grantcharov
Notes: Ways to assess team performance
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer. BJS 2018; 105: 900-906.
Authors: M. Navidi, A. W. Phillips, S. M. Griffin, K. E. Duffield, A. Greystoke, K. Sumpter et al.
Notes: Chemotherapy reduces cardiopulmonary reserve
Randomized clinical trial
Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer. BJS 2018; 105: 502-511.
Authors: K. Valkenet, J. C. A. Trappenburg, J. P. Ruurda, E. M. Guinan, J. V. Reynolds, P. Nafteux et al.
Notes: Increased muscle function, no better outcome